Bank of Montreal’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-31,974
Closed -$1.63M 4022
2023
Q2
$1.63M Buy
+31,974
New +$1.44M ﹤0.01% 1920
2021
Q2
Sell
-179
Closed -$4K 4275
2021
Q1
$4K Sell
179
-944
-84% -$22.6K ﹤0.01% 4734
2020
Q4
$26K Sell
1,123
-26,899
-96% -$622K ﹤0.01% 4301
2020
Q3
$588K Sell
28,022
-2,325
-8% -$52.2K ﹤0.01% 2260
2020
Q2
$713K Buy
30,347
+1,697
+6% +$36.4K ﹤0.01% 2092
2020
Q1
$561K Buy
28,650
+1,339
+5% +$31.9K ﹤0.01% 1926
2019
Q4
$639K Buy
27,311
+26,714
+4,475% +$624K ﹤0.01% 2525
2019
Q3
$12K Buy
597
+19
+3% +$388 ﹤0.01% 4351
2019
Q2
$12K Buy
578
+378
+189% +$8.9K ﹤0.01% 4444
2019
Q1
$6K Sell
200
-50
-20% -$1.31K ﹤0.01% 3994
2018
Q4
$6K Buy
250
+226
+942% +$6.07K ﹤0.01% 4022
2018
Q3
$1K Sell
24
-1
-4% -$27 ﹤0.01% 4544
2018
Q2
$1K Buy
+25
New +$442 ﹤0.01% 4539

Other funds holding IRMD

Bank of Montreal's IRMD Position: Q3 2023 in Review

Bank of Montreal sold out of iRadimed (IRMD) in Q3 2023, closing a stake of 31,974 shares — an estimated $1.63M sold.

Bank of Montreal first reported a position in IRMD in Q2 2018 and held it in 13 quarters. The position peaked at $1.63M in Q2 2023. 114 funds tracked by Wall St. Rank hold IRMD as of Q3 2023.

  • Bank of Montreal reported no remaining iRadimed position as of Q3 2023 after selling out during the quarter.
  • Bank of Montreal sold 31,974 iRadimed shares in Q3 2023, an estimated $1.63M.
  • Bank of Montreal first reported a position in iRadimed in Q2 2018 and held it in 13 quarters.
  • Bank of Montreal's iRadimed position peaked at $1.63M in Q2 2023.
  • 114 funds tracked by Wall St. Rank held iRadimed as of Q3 2023.

Based on Bank of Montreal's 13F filing for Q3 2023, filed 1 Nov 2023.